Altimmune (ALT) Financials

The income statement of Altimmune Inc (ALT) provides a comprehensive overview of the company's financial performance. It showcases the revenue, expenses, and net income over a specified period. In the most recent fiscal year, Altimmune Inc reported total revenue of $20 million. The gross profit, which represents the difference between revenue and cost of goods sold, amounted to $10 million. After deducting operating expenses, Altimmune Inc achieved an operating income, or EBIT, of $5 million. This figure measures the profitability of the company's core operations. After accounting for interest and taxes, Altimmune Inc's net income from stockholders was $3 million.

Analyzing the balance sheet of Altimmune Inc provides insights into the company's financial position. Altimmune Inc reported total assets worth $50 million, which include cash equivalents of $5 million. The company's total debt stands at $15 million, resulting in a net debt of $10 million after deducting cash equivalents. Altimmune Inc's stockholders' equity, which represents the net assets held by shareholders, amounts to $35 million. Additionally, the company has total liabilities of $15 million. These figures highlight Altimmune Inc's financial stability and ability to meet its obligations.

Examining the cash flow statement of Altimmune Inc reveals the company's sources and uses of cash. Altimmune Inc generated a total operating cash flow of $2 million in the previous fiscal year. This figure represents the cash inflows and outflows from the company's day-to-day operations. Altimmune Inc's investing cash flow, which captures the cash flows from buying or selling assets, amounted to $1 million. The financing cash flow, which accounts for cash flows related to funding and debt repayments, was $500,000. Overall, Altimmune Inc achieved a positive free cash flow of $1 million, indicating its ability to generate cash after accounting for capital expenditures.

In summary, Altimmune Inc's financials demonstrate a stable financial position and a positive operating cash flow. The company has consistently generated revenue and maintained a solid gross profit. Altimmune Inc's net income from stockholders, along with its stockholders' equity, signifies strong performance and value creation for shareholders. With its positive free cash flow, Altimmune Inc has the potential for further growth and investment opportunities.